(Q45219652)

English

The effects of acute loading with levodopa and levodopa with selegiline on blood pressure and plasma norepinephrine levels in chronic Parkinson's disease patients

scientific article published in February 2005

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

The effects of acute loading with levodopa and levodopa with selegiline on blood pressure and plasma norepinephrine levels in chronic Parkinson's disease patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

0 references

1 reference

based on heuristic

inferred from title

Parkinson's disease

1 reference

based on heuristic

inferred from title

author name string

Stryjer R

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Klein C

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Treves TA

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Rabey JM

4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

language of work or name

0 references

publication date

1 February 2005

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Acta Neurologica Scandinavica

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

111

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

89-94

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Implications of combined treatment with 'Madopar' and L-deprenil in Parkinson's disease. A long-term study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00294.X

21 January 2018

Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00294.X

21 January 2018

Effect of selegiline on mortality in patients with Parkinson's disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00294.X

21 January 2018

Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00294.X

21 January 2018

Deprenyl is metabolized to methamphetamine and amphetamine in man

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00294.X

21 January 2018

Deprenil: loss of selectivity for inhibition of B-type MAO after repeated treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00294.X

21 January 2018

Does the B form selective monoamine oxidase inhibitor lose selectivity by long term treatment?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00294.X

21 January 2018

Normal cerebral hemodynamic response to orthostasis in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0404.2005.00294.X

21 January 2018

Identifiers

10.1111/J.1600-0404.2005.00294.X

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45219652&oldid=2070425372"